NDC 0310-0900

DUAKLIR PRESSAIR

Aclidinium Bromide And Formoterol Fumarate

DUAKLIR PRESSAIR is a Respiratory (inhalation) Powder, Metered in the Human Prescription Drug category. It is labeled and distributed by Astrazeneca Pharmaceuticals Lp. The primary component is Aclidinium Bromide; Formoterol Fumarate.

• Product ID: 0310-0900_8a53bfe1-e02e-46c3-a8b4-54f89d4897c2
• NDC: 0310-0900
• Product Type: Human Prescription Drug
• Proprietary Name: DUAKLIR PRESSAIR
• Generic Name: Aclidinium Bromide And Formoterol Fumarate
• Dosage Form: Powder, Metered
• Route of Administration: RESPIRATORY (INHALATION)
• Marketing Start Date: 2022-08-17
• Marketing End Date: 2025-04-30
• Marketing Category: NDA /
• Application Number: NDA210595
• Labeler Name: AstraZeneca Pharmaceuticals LP
• Substance Name: ACLIDINIUM BROMIDE; FORMOTEROL FUMARATE
• Active Ingredient Strength: 400 ug/1; ug/1
• Pharm Classes: Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]
• NDC Exclude Flag: N

Packaging

NDC 0310-0900-30

1 POUCH in 1 CARTON (0310-0900-30) > 1 INHALER in 1 POUCH > 30 POWDER, METERED in 1 INHALER

• Marketing Start Date: 2022-08-17
• Marketing End Date: 2024-09-30
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "DUAKLIR PRESSAIR" or generic name "Aclidinium Bromide And Formoterol Fumarate"

NDC	Brand Name	Generic Name
0310-0900	DUAKLIR PRESSAIR	aclidinium bromide and formoterol fumarate
72124-001	DUAKLIR PRESSAIR	aclidinium bromide and formoterol fumarte